ArticleBMC oral health2025
Stroke-related parameters affecting the deterioration of oral health-related quality of life as measured by OHIP-14 three months after ischemic stroke.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesOral health-related quality of life (OHRQoL) depends not only on oral diseases and hygiene but also on various psychosocial and medical conditions, including stroke and its complications. This study aimed to identify parameters influencing deterioration of OHRQoL, measured with the Oral Health Impact Profile-14 (OHIP-14) questionnaire from the acute stroke onset to 3 months later.
methodsWe prospectively analyzed data from 392 participants in the iBioStroke project, all of whom completed OHIP-14 questionnaire during the acute phase of ischemic stroke and again 3 months after its onset. We considered 37 demographic, clinical, radiological, and biochemical parameters available during the acute phase of stroke, as well as cognitive and mood disturbances that occurred during the follow-up period between two groups: Group I, consisting of patients whose OHIP-14 scores remained stable or decreased (OHRQoL stable or improved) by at least 1 point between the acute phase of stroke and 3 months after its onset, and Group II, comprising those whose OHIP-14 scores increased (OHRQoL deteriorated) by at least 1 point in the total score over the same period of time.
resultsUnivariate regression testing revealed that patients in Group II (n = 189), compared to Group I (n = 203), more frequently presented with consistent anxiety (OR = 2.67, 95%CI: 1.49-4.87, p = 0.001) and consistent depression (OR = 2.10, 95%CI: 1.07-4.23, p = 0.033). Additionally, they were more likely to experience deterioration of pre-existing anxiety (OR = 2.88, 95%CI: 1.64-5.14, p < 0.001) and depression (OR = 2.42, 95%CI: 1.45-4.11, p < 0.001). Patients who experienced deterioration in their OHRQoL exhibited higher platelet count (mean values: 235.5 ± 78.7 vs. 218.2 ± 62.8 × 10
conclusionsOur study reveals that over 48% of ischemic stroke patients experience a decline in their OHRQoL. Our findings also highlight the necessity for vigilant monitoring of post-stroke anxiety both during the acute phase of stroke and throughout follow-up, as it impacts the risk of deterioration in OHRQoL. This issue holds significance because post-stroke anxiety is treatable with psychological and pharmacological interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.